Literature DB >> 25666714

A magnetic nanoparticle-based time-resolved fluoroimmunoassay for determination of the cytokeratin 19 fragment in human serum.

Guanfeng Lin1, Tiancai Liu, Jingyuan Hou, Zhiqi Ren, Jianwei Zhou, Qianni Liang, Zhenhua Chen, Wenqi Dong, Yingsong Wu.   

Abstract

A sensitive, rapid and novel measurement method for cytokeratin 19 fragment (CYFRA 21-1) in human serum by magnetic particle-based time-resolved fluoroimmunoassay (TRFIA) is described. Built on a sandwich-type immunoassay format, analytes in samples were captured by one monoclonal antibody coating onto the surface of magnetic beads and "sandwiched" by another monoclonal antibody labeled with europium chelates. The coefficient variations of the method were lower than 7%, and the recoveries were in the range of 90-110% for serum samples. The lower limit of quantitation of the present method for CYFRA 21-1 was 0.78 ng/ml. The correlation coefficient of CYFRA 21-1 values obtained by our novel TRFIA and CLIA was 0.980. The present novel TRFIA demonstrated high sensitivity, wider effective detection range and excellent reproducibility for determination of CYFRA 21-1 can be useful for early screening and prognosis evaluation of patients with non-small cell lung cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25666714     DOI: 10.1007/s10895-015-1518-0

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  38 in total

1.  Analytical and clinical evaluation of CYFRA 21-1 by electrochemiluminescent immunoassay in head and neck squamous cell carcinoma.

Authors:  Christiane Kuropkat; Jochen A Werner
Journal:  J Laryngol Otol       Date:  2003-12       Impact factor: 1.469

2.  Functional magnetic nanoparticle-based trapping and sensing approaches for label-free fluorescence detection of DNA.

Authors:  Ju-Yu Lin; Yu-Chie Chen
Journal:  Talanta       Date:  2011-09-17       Impact factor: 6.057

Review 3.  Clinical practice. Lung cancer screening.

Authors:  James L Mulshine; Daniel C Sullivan
Journal:  N Engl J Med       Date:  2005-06-30       Impact factor: 91.245

4.  Development of high-performance magnetic chemiluminescence enzyme immunoassay for alpha-fetoprotein (AFP) in human serum.

Authors:  Xu Wang; Qian-Yun Zhang; Zhen-Jia Li; Xi-Tang Ying; Jin-Ming Lin
Journal:  Clin Chim Acta       Date:  2008-03-20       Impact factor: 3.786

5.  Determination of hormones by time-resolved fluoroimmunoassay.

Authors:  T Lövgren; I Hemmilä; K Pettersson; J U Eskola; E Bertoft
Journal:  Talanta       Date:  1984-10       Impact factor: 6.057

6.  Time-resolved fluoroimmunoassay for plasma enterolactone.

Authors:  H Adlercreutz; G J Wang; O Lapcík; R Hampl; K Wähälä; T Mäkelä; K Lusa; M Talme; H Mikola
Journal:  Anal Biochem       Date:  1998-12-15       Impact factor: 3.365

7.  Development of an immunomagnetic bead-based time-resolved fluorescence immunoassay for rapid determination of levels of carcinoembryonic antigen in human serum.

Authors:  Jing-Yuan Hou; Tian-Cai Liu; Guan-Feng Lin; Zhi-Xiong Li; Li-Ping Zou; Ming Li; Ying-Song Wu
Journal:  Anal Chim Acta       Date:  2012-05-14       Impact factor: 6.558

Review 8.  Fluoroimmunoassays and immunofluorometric assays.

Authors:  I Hemmilä
Journal:  Clin Chem       Date:  1985-03       Impact factor: 8.327

9.  Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of response.

Authors:  Robin T Vollmer; Ramaswamy Govindan; Stephen L Graziano; Gary Gamble; Jennifer Garst; Michael J Kelley; Robert H Christenson
Journal:  Clin Cancer Res       Date:  2003-05       Impact factor: 12.531

10.  Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.

Authors:  M Takada; N Masuda; E Matsuura; Y Kusunoki; K Matui; K Nakagawa; T Yana; I Tuyuguchi; I Oohata; M Fukuoka
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

View more
  1 in total

1.  A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency.

Authors:  Guanfeng Lin; Shaolang Chen; Hui Zhao; Junyu Liang; Qiaoting Deng; Rongliang Liang; Xinxin Guo; Zhenhua Chen; Baihong Chen; Tiancai Liu; Yingsong Wu
Journal:  Sci Rep       Date:  2017-08-04       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.